Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Articles by Jill Wechsler

Republican gains in Congress create uncertainty for healthcare reform, drug regulation, and biomedical research.
Dec 2, 2010
By: Jill Wechsler

Republican gains in Congress create uncertainty for healthcare reform, drug regulation, and biomedical research.

A new center may provide evidence for improving care, but could discourage coverage of treatments.
Nov 2, 2010
By: Jill Wechsler

A new center may provide evidence for improving care, but could discourage coverage of treatments.

President Obama and HHS eye innovation and countermeasures to protect public health.
Oct 2, 2010
By: Jill Wechsler

President Obama and HHS eye innovation and countermeasures to protect public health.

Weighing the pros and cons of REMS for bringing risky products to market.
Sep 2, 2010
By: Jill Wechsler

Weighing the pros and cons of REMS for bringing risky products to market.

Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.
Aug 2, 2010
By: Jill Wechsler

Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.

More information may be released to improve public understanding of regulatory policies.
Jul 2, 2010
By: Jill Wechsler

More information may be released to improve public understanding of regulatory policies.

FDA and industry seek to ensure drug quality and safety in a world complicated by global outsourcing and rising theft.
Jun 2, 2010
By: Jill Wechsler

FDA and industry seek to ensure drug quality and safety in a world complicated by global outsourcing and rising theft.

Manufacturers will pay new fees but anticipate expanded drug use and safeguards for innovation.
May 2, 2010
By: Jill Wechsler

Manufacturers will pay new fees but anticipate expanded drug use and safeguards for innovation.

FDA lacks resources to manage expanding postmarketing responsibilities.
Apr 2, 2010
By: Jill Wechsler

FDA lacks resources to manage expanding postmarketing responsibilities.

Survey

How does your company apply quality-by-design (QbD) principles to manufacturing processes?

Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe
Providing the latest business, scientific, and regulatory news for the pharmaceutical and biotech industries. WEEKLY Archives Subscribe	Covers small and large- molecule pharmaceutical manufacturing, ingredients sourcing, and the pharmaceutical supply chain. MONTHLY Archives Subscribe	Focuses on pharmaceutical manufacturing processes and technology, featuring a showcase of processing equipment and reviews. MONTHLY Archives Subscribe	News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts. WEEKLY Subscribe